Holen Sie sich die Stockscreener-App
58.86
44.26%
18.06
Handel nachbörslich:
59.48
0.62
+1.05%
Schlusskurs vom Vortag:
$40.80
Offen:
$54.93
24-Stunden-Volumen:
2.29M
Relative Volume:
4.67
Marktkapitalisierung:
$1.61B
Einnahmen:
$86.93M
Nettoeinkommen (Verlust:
$-1.48M
KGV:
-830.18
EPS:
-0.0709
Netto-Cashflow:
$431.00K
1W Leistung:
+31.97%
1M Leistung:
+56.92%
6M Leistung:
+244.82%
1J Leistung:
+252.46%
1-Tages-Spanne:
$53.01
$59.79
1-Wochen-Bereich:
$40.61
$59.79
52-Wochen-Spanne:
$14.27
$59.79
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
58.86 | 1.14B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Eton Pharmaceuticals Stock Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Responsive Playbooks and the ETON Inflection - Stock Traders Daily
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes - StocksToTrade
Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars As Q2 Beat Triggers Aggressive Target Hikes - StocksToTrade
86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC - marketbeat.com
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance? - Yahoo Finance
Why Eton Pharmaceuticals Is Top of the Class Today - The Motley Fool
Eton Pharmaceuticals Soars 39% After Earnings Beat and Upgraded Guidance - finance.biggo.com
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Stocktwits
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
ETON Stock Soars After Blowout Earnings And Guidance Hike - StocksToTrade
Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation - ts2.tech
Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These - Seeking Alpha
Eton Pharmaceuticals stock hits all-time high at 55.07 USD By Investing.com - Investing.com South Africa
Why is Eton Pharmaceuticals stock surging today? By Investing.com - Investing.com Canada
Eton Pharmaceuticals stock hits all-time high at 55.07 USD - Investing.com
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year High Following Earnings Beat - marketbeat.com
Eton Pharmaceutical (ETON) Stock Forum and Discussion - Moomoo
Why is Eton Pharmaceuticals stock surging today? - Investing.com
Eton Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating - marketscreener.com
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday - benzinga.com
ETON SWOT Analysis: Financial Insights from 10-Q Filing - GuruFocus
Eton Pharmaceuticals Q2 2026 Earnings Call Transcript - marketbeat.com
Eton Pharmaceuticals Q2 Earnings Call Highlights - marketbeat.com
ETON PHARMACEUTICALS ($ETON) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings call transcript: Eton Pharmaceuticals tops Q2 2026 estimates, shares jump - Investing.com
Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Eton Pharmaceuticals Q2 Results: Revenue up 99%, EBITDA margin expands to 43% - scanx.trade
Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript - Benzinga
ETON: Record revenue, margin expansion, and portfolio growth drive raised 2026 guidance - TradingView
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Beats Expectations By $0.28 EPS - marketbeat.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance By Investing.com - Investing.com South Africa
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON - StreetInsider
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance - Investing.com
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON By Investing.com - Investing.com Australia
Eton Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Eton Pharmaceuticals (NASDAQ: ETON) swings to H1 2026 profit on revenue jump - Stock Titan
Eton Pharmaceuticals posts Q2 2026 revenue $37.6M, GAAP EPS $0.35 and raises 2026 revenue outlook - TradingView
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-Eton Pharmaceuticals Q2 Net Income USD 11.578 Million - TradingView
Eton Now Expects 2026 Revenue to Exceed $145M After Q2 - Stock Titan
Eton Pharmaceuticals earnings ahead: Profitability in focus By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals earnings ahead: Profitability in focus - Investing.com
Equities Analysts Issue Forecasts for ETON FY2027 Earnings - marketbeat.com
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
5.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):